"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

People are at the heart of the HIV pandemic, so it’s important to understand how they make protection decisions.

Gilead (GILD) announced The New England Journal of Medicine, or NEJM, published the full results from the company’s pivotal ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themselves. But ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

The number of new HIV infections and deaths has fallen across the world, marking significant progress in the fight against ...

Research shows many transgender women in the U.S. express interest in long-acting injectable PrEP but face barriers to ...

A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published ...

In Uganda, women and girls are more affected by HIV. Out of 1.4 million people living with the disease, 860 000 are women and ...

Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...